Should Investors Trust The Upside Potential In Quoin Pharmaceuticals Ltd ADR (QNRX)?

Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) currently has a daily average trading volume of 3.60M but it saw 776438 shares traded in last market. With a market cap of 1.65M USD, the company’s current market price of $0.33 came rising about 5.65 while comparing to the previous closing price of $0.31. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.18 and as low as $0.28.

Taking a look at 20-day trading activity of Quoin Pharmaceuticals Ltd ADR (QNRX) gives us an average price of $0.3358, while its current price level is -94.70% below from 52-week high level whereas it is 16.51% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5173 while that of 200 days or SMA-200 reads an average of $0.6157. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.48% during that period while stretching the period over a month that increases to 15.76%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.14 which implies that the stock is in neutral territory.

Over the week, QNRX’s stock price is moving 9.17% up while it is -42.66% when we observe its performance for the past one month. Year-to-date it is -49.67% down and over the past year, the stock is showing a downside performance of -88.26%.

The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.43 while estimate for next year EPS is -2.05.

Currently, Quoin Pharmaceuticals Ltd ADR’s total number of outstanding shares is 5.05M with 16.88% of that held by the insiders while 18.89% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -160.77% and return on equity (ROE) at -136.11%. Stock’s beta reads 1.83. Stock has a price to book (P/B) ratio of 0.30. Its return on asset (ROA) is -66.14% on average.